Discovery and initial SAR of inhibitors of interleukin-1 receptor-associated kinase-4.
High-throughput screening of a small-molecule compound library resulted in the identification of a novel series of N-acyl 2-aminobenzimidazoles that are potent inhibitors of interleukin-1 receptor-associated kinase-4.